Elanco Animal Health Incorporated

ELAN Healthcare Drug Manufacturers Specialty & Generic

Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.

Revenue
+10.2%
EPS
+450.0%
Free cash flow
+35.6%
Total debt
−6.91%

Quarter to June 2026, against a year earlier

23.74 1.57 −6.20%
Market cap
$11.8B
P/E
0.0×
Fwd P/E
161×
Dividend yield
—
F-score
5/9
Altman Z
1.28
Beneish M
−2.68
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — 6 6 1 7 5 4 6 5
P/E ratio
0.00 0.00 134.86 155.00 0.00 0.00 0.00 0.00 17.81 0.00
P/S ratio
0.00 0.00 3.23 3.54 4.14 2.90 1.37 1.63 1.35 2.38
Altman Z-Score
— — 2.20 2.53 0.99 1.18 0.79 0.61 0.89 1.28
Altman Z″-Score (non-manufacturers)
— — 2.72 3.00 1.11 1.20 1.47 0.88 1.52 1.40
P/FCF ratio
43.96 43.96 27.31 0.00 0.00 48.35 22.50 61.60 16.08 42.88
Beneish M-Score
— (2.73) (3.94) (2.34) (2.47) (2.78) (2.67) (3.00) (2.64) (2.68)
P/Operating CF
77.13 77.13 70.90 86.11 (145.57) 62.00 463.89 45.91 33.80 104.01
P/B ratio
1.50 1.50 1.90 1.96 1.60 1.84 0.83 1.16 0.98 1.72
EV/Sales
0.00 0.00 3.81 4.19 5.86 4.09 2.61 2.86 2.22 3.12
EV/EBITDA
0.00 0.00 24.29 25.81 0.00 50.54 13.05 0.00 12.89 21.16
EV/FCF
42.88 42.88 32.26 (218.25) (68.42) 68.21 42.99 107.94 26.44 56.13
Current Ratio
3.15 3.30 2.58 2.90 1.65 1.99 1.93 2.75 2.44 2.17
Net Debt/EBITDA
(1.13) (3.77) 3.73 4.03 (29.90) 14.72 6.22 (36.39) 5.05 5.00
Debt/Equity
0.00 0.00 0.48 0.42 0.72 0.84 0.80 0.93 0.71 0.61
ROE
(0.65%) (4.20%) 1.33% 1.27% (8.19%) (6.04%) (1.05%) (18.22%) 5.49% (3.67%)
ROA
(1.18%) (3.65%) 0.97% 0.76% (4.30%) (2.83%) (0.49%) (8.25%) 2.51% (1.79%)
ROIC
(0.23%) (1.95%) 1.65% 1.53% (3.13%) (1.56%) 0.98% (4.52%) 0.63% 0.09%
Return on Tangible Assets
(2.31%) (12.94%) 3.52% 2.71% (21.61%) (18.01%) (3.03%) (38.57%) 11.68% (7.09%)
Average Days of Receivables
79.01 76.04 84.43 105.77 120.18 78.76 82.91 83.46 72.85 72.77
Earnings Yield
(2.72%) (2.72%) 0.74% 0.65% (3.91%) (3.38%) (1.06%) (17.08%) 5.62% (2.08%)
Free Cash Flow Yield
2.27% 2.27% 3.66% (0.54%) (2.07%) 2.07% 4.44% 1.62% 6.22% 2.33%
Free Cash Flow per Share
0.18 0.32 1.15 0.07 (0.63) 0.59 0.55 0.24 0.77 0.57
Book value per Share
23.96 26.53 16.57 15.03 19.20 15.41 14.93 12.64 12.34 13.19
Free Cash Flow
53.00 94.30 360.20 27.00 (280.00) 286.00 268.00 117.00 380.00 284.00
EV/EBIT
0.00 0.00 63.17 69.61 0.00 0.00 57.32 0.00 97.38 980.37
Other line items

Show all line items

Columns are period end dates